2026年02月02日 星期一

> SARS-CoV Urbani滴鼻感染BALB/c小鼠模型

中文名称Chinese name SARS-CoV Urbani滴鼻感染BALB/c小鼠模型
编号Model number
英文名称English name SARS-CoV intranasally infection mouse model
物种Species name 小鼠
品系Strain name BALB/c小鼠
人类疾病Human diseases SARS
传染性Infectivity
微生物Microorganism
类别Category SARS-CoV感染动物模型 
造模因素Modeling factors
制作方法Making method 4–6-week-old female BALB/c mice (Taconic) were housed in cages with 4 mice per cage. Mice received 400 mL MAb or serum by intraperitoneal (ip) injection. The mice were bled the next day to determine the level of neutralizing antibody achieved, and lightly anesthetized mice were challenged with 10^5 TCID50 of SARS-CoV, administered intranasally. Efficacy of immunoprophylaxis in mice challenged with severe acute respiratory syndrome (SARS)–associated coronavirus (SARS-CoV). Mice (4 in each group) were treated with the indicated monoclonal antibody (MAb), at estimated doses of 40, 8, and 1.6 mg/kg, 1 day prior to intranasal challenge with 105 TCID50 of SARS-CoV.
生物学特征Biological characteristics
医学用途Medical use 用于SARS-CoV致病机制研究、疫苗和药物评估。 
临床表现Clinical manifestation
病理表现Pathology
发病天数Days of onset
发病过程Pathogenesis process
临床诊断Clinical diagnosis 病毒在肺中复制
评价模型成功的指标Indicators for evaluating model success
保藏单位Preservation unit 马萨诸塞大学医学院@@https://umassmed.edu/
参考文献Reference Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.,PMID:15655773,DOI:10.1086/427242
录入/更新时间Date 2021.7.20
备注Remarks
返回顶部